Author:
Schwenzer-Zimmerer K.,Kansy K.,Zeilhofer H.-F.,Zippelius A.,Zimmermann F.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92–98
2. Bernier J, Cooper JS, Pajak TF et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27:843–850
3. Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. European Organization for Research and Treatment of Cancer Trial 22931. N Engl J Med 350(19):1945–1952
4. Bier J, Howaldt HP, Pitz H (1992) 4th German-Austrian-Swiss Study Group therapy study. Prospective, randomized, clinical study of squamous cell cancer of the mouth: radical neck dissection versus conservative neck dissection. Fortschr Kiefer Gesichtschir 37:108–110
5. Bitter K (1972) Pharmacokinetic studies on the intra-arterial application of methotrexate in the maxillofacial region. Osterr Z Stomatol 69:262–269